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Conclusion: The larynx preservation protocol achieves the 
same survival rates that total laryngectomy, contributing 50% 
of preservation of organ function. It is necessary more cases 
for a final evaluation.  
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Purpose or Objective: To robustly assess features of 
radiotherapy-induced fibrosis in patients within the 
reconstructive/plastic surgery clinic and establish a baseline 
for comparison against following treatment.  
 
Material and Methods: Patients awaiting fat-graft treatment 
for radiotherapy-induced fibrosis were assessed with regard 
to their symptomatology using a quality of life questionnaire. 
They also underwent clinical examination for functional 
impairment secondary to the fibrotic process and assessment 
of the microcirculation and mechanical properties by speckle 
contrast blood flow assessment and themographic imaging, 
durometry and skin cutometry respectively. The results were 
compared against age-matched healthy controls.  
 
Results: Health-related quality of life in these patients was 
impaired, with 36% of patients overall rating their quality as 
“fair” or “very poor”. On clinical assessment, movement of 
the neck was impaired with approximately 50% reduction in 
flexion and rotation movements. 100% of patients had 
sensory impairment in the fibrotic region. Microcirculatory 
changes were seen with increased flux (mean = 411.47 vs. 
348.83 contralaterally) and temperature (mean difference of 
1.3°C vs. control) in the regions of fibrotic change compared 
with the contralateral side and with controls respectively. 
Significant differences in hardness of skin and subcutaneous 
tissues of the neck were seen between treated and untreated 
areas and between patients and controls (51.5 vs. 16.8 
durometer units). Significant increases in the firmness and 
fatiguability of the skin were seen on cutometry and non-
significant decreases in elasticity.  
 
Conclusion: Our methods provide us with important baseline 
information about how affected our patients are by 
radiotherapy-induced fibrosis. This baseline can be compared 
post-operatively to quantify benefits afforded by fat-graft 
treatment and guide future research into the underlying 
mechanisms. 
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Purpose or Objective: To assess efficacy & toxicity of 
reduced CTV margins in the IMRT of head and neck cancers 
 
Material and Methods: Between 2010 and 2015, 83 
consecutive patients with locally advanced Head & Neck 
squamous cell cancers, treated with a radical intent with 
chemoradiation by IMRT, with reduced CTV margins were 
analysed for local control, toxicity, compliance & survival. 
Nodal delineation was as per DAHANCA guidelines.Toxicity 
was assessed by CTCAE version 4.0 
 
Results: Median age of the cohort was 58 years (32-76) with 
65 males & 18 female patients. Hypopharyngeal cancers were 
47% followed by oropharyngeal (27%) and laryngeal (26%) 
cancers. TNM stage grouping in the cohort was IVA in 72% 
followed by IVB & III. CECT based delineation of the involved 
primary and nodal volumes were expanded uniformly by 5 
mm to create the high risk CTV and this expanded by 5 mm to 
create the PTV1. Similarly the involved nodal level was 
considered as intermediate risk (PTV2) and remaining nodal 
levels as low risk (PTV3). Inverse planning was performed 
using Varian Eclipse planning system with dose constraints to 
OAR’s as per guidelines. SIB-IMRT was delivered to a dose 70, 
63 and 56Gy in 35 fractions to high, intermediate and low risk 
volumes respectively. Median overall treatment time was 
49(40-70) days. 24% of the patients received 6 fractions per 
week. Weekly Cisplatin (40mg/sqm) was given concurrently 
with IMRT except in 10 patients receiving Carboplatin (2AUC), 
90% received a minimum of 4 cycles. Grade 3 mucositis was 
seen in 40%, grade 3 dysphagia in 6%, radiation dermatitis 
was predominantly grade 2, Xerostomia was predominantly 
grade 1 in 93%, 10% required placement of nasogastric tube 
and treatment interruption. Myelosuppression of grade 3 was 
seen towards completion of treatment in 24% of the cohort, 
predominantly in total leukocyte count. A complete response 
of 90% and 86% was seen in primary and nodal disease at the 
end of the treatment and eventually in 100% and 94% in first 
three months. 3 patients needed neck dissection and showed 
residual disease. At a median follow up of 2 years, 62 
patients are controlled with an overall survival of 74.7%. 
Deaths are due to distant metastasis in 4% and 8% due to 
other medical causes.  
 
Conclusion: Reduction of CTV margin to 5 mm seems to be 
appropriate, with good loco-regional control, reduced overall 
treatment time, better compliance, reduced toxicity & 
superior outcomes. This study forms basis for a prospective 
controlled randomised study to generate further evidence. 
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Purpose or Objective: Significant shoulder dysfunction 
persists in a majority of the oral cancer patients after surgery 
even on performing active exercises. Progressive Resistive 
Exercise Training (PRET) involves gradual and incremental 
increase in resistance for improved muscular rehabilitation. 
This randomized controlled trial was done to compare active 
shoulder exercise and PRET with active exercises for shoulder 
dysfunction in patients undergoing Radiation Therapy (RT).  
 
Material and Methods: Ninety four eligible patients with 
shoulder abduction Active Range of Motion (AROM) ≤ 90° 
were randomized to either active shoulder exercises only ( 
n=47) or PRET plus active shoulder exercises (n=47). 
Resistance was gradually progressed over 6 weeks according 
to the capacity of patients in PRET arm. AROM was measured 
at week 0, 2, 4, 6 and 6 months. Shoulder Pain and Disability 
Index (SPADI) was also measured in both arms at the base 
line and after completion of the intervention at the end of 
6th week.  
 
Results: Results: Improvement in shoulder abduction AROM 
was significantly greater in the PRET Arm (mean = 73.3° ± 
14.3° at baseline to 132.5° ± 28.5° at 6 weeks) than in 
standard arm (mean = 74.8° ± 12.5° at baseline to 97.1° ± 
